Poor response to treatment of renal anaemia with erythropoietin corrected by iron given intravenously.
about
Meta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published trial dataMelatonin: reducing the toxicity and increasing the efficacy of drugsParenteral iron supplementationThe predictive parameters of erythropoietin hyporesponsiveness in patients on continuous ambulatory peritoneal dialysisErythropoietin, protein, and iron supplementation and the prevention of anaemia of prematurity.Heme iron polypeptide for the treatment of iron deficiency anemia in non-dialysis chronic kidney disease patients: a randomized controlled trial.Abnormally high serum ferritin levels among professional road cyclistsDetection of functional iron deficiency during erythropoietin treatment: a new approach.Iron deficient erythropoiesis might play key role in development of anemia in cancer patients.Haematology.Hepatic iron in dialysed patients given intravenous iron dextran.Comparison of short-term efficacy of iron sucrose with those of ferric chloride in hemodialysis patients: An open-label study.The use of erythropoietin in renal failure.Should we reconsider iron administration based on prevailing ferritin and hepcidin concentrations?Treating renal anaemia with recombinant human erythropoietin: practical guidelines and a clinical algorithm.Resistance to recombinant human erythropoietin due to aluminium overload and its reversal by low dose desferrioxamine therapy.Iron management during treatment with recombinant human erythropoietin in chronic renal failure.Influence of disease on iron status.Serum hepcidin levels and reticulocyte hemoglobin concentrations as indicators of the iron status of peritoneal dialysis patients.Role of erythropoietin in the newborn.Functional iron deficiency during erythropoietin treatment.Withdrawal of a monopoly treatment.Poor response to erythropoietin.Nontransferrin-bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion.Guideline for the laboratory diagnosis of functional iron deficiency.Effective utilization of erythropoietin with intravenous iron therapy.Novel Haematological Parameters in Patients Receiving Recombinant Human Erythropoietin and Undergoing Haemodialysis.The hypochromic red cell: a new parameter for monitoring of iron supplementation during rhEPO therapy.
P2860
Q21261840-022E939A-03DF-474F-A896-2F09C57A3CEAQ28194026-D4AFA76C-02F4-4096-A172-E12E138EAD1FQ28305904-47C6CDFC-FF6D-4D85-A464-D58ED0C8CFD2Q28361138-BC6AA30E-D501-4BDE-A11E-329431483E5FQ33623591-C03DECC9-53D5-484F-ACAA-FD7632A82AA3Q34628344-61CA03CC-FC85-4897-B4EB-296C5DDD779DQ35330603-720634E6-1645-4809-B40F-C21ACF94325AQ35820499-5ADE8443-D72C-405A-8221-0DF886C7CA98Q36619022-1D46C0A9-A219-4723-ADF9-2DC921BAEE0AQ36723863-89F91CA4-5EB3-42A9-B6D9-09FE6D517CAEQ37255502-0E19A317-C735-4342-B23B-759269847E27Q37593694-6F4EA436-FD7D-4860-BB66-A82670ACF484Q37767350-AF8F1E6B-00FA-4C74-8791-A39DDB455EBDQ38051056-05C3BFDA-793F-4ED0-AD92-B366E300164DQ38066210-61D003B1-50A1-4A98-9FCC-95C45AF120D5Q38659005-A2DCFD56-9237-4D4B-912C-3B5190892583Q40724260-A304A35D-75E2-4E56-A31F-01648C322F01Q41486322-627EB6D8-65B8-4FEB-BF14-56F0FD4E4AECQ41546176-DB90D3DC-3C57-47F2-A4BB-7D9E3F865BFCQ42584310-1490D823-408A-4503-87AD-FE0193069280Q42763195-4434B559-5502-4907-B7F8-A2819085E8FDQ42763343-181038F0-3094-46C3-AFB8-072E84B2BF24Q43298119-D2D624F0-9B7C-4CD6-8050-F676F52F436CQ43910629-BFDC59D7-232D-44A2-9EC8-46A9C871CBA4Q51076582-7D8DE416-A4E7-482F-8D78-55F2EEA22F2DQ52866695-4B3D772C-FF4C-43D9-8853-16748CCABE49Q52867582-0B917541-F3A9-42E7-8658-FE755C444A3FQ54571080-2164E36C-4B89-48D4-99D9-B9B6201B8C48
P2860
Poor response to treatment of renal anaemia with erythropoietin corrected by iron given intravenously.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Poor response to treatment of ...... d by iron given intravenously.
@ast
Poor response to treatment of ...... d by iron given intravenously.
@en
type
label
Poor response to treatment of ...... d by iron given intravenously.
@ast
Poor response to treatment of ...... d by iron given intravenously.
@en
prefLabel
Poor response to treatment of ...... d by iron given intravenously.
@ast
Poor response to treatment of ...... d by iron given intravenously.
@en
P2093
P356
P1433
P1476
Poor response to treatment of ...... d by iron given intravenously.
@en
P2093
Macdougall IC
Williams JD
P304
P356
10.1136/BMJ.299.6692.157
P407
P577
1989-07-01T00:00:00Z